SPONSOR
Imperial College London
Total Trials
11
Recruiting
11
Phases
N/A
Conditions studied: Oesophageal Squamous Cell CarcinomaOesophageal AdenocarcinomaGastric AdenocarcinomaPancreatic Ductal Adenocarcinoma (PDAC)CholangiocarcinomaHepatocellular Carcinoma (HCC)Colorectal AdenocarcinomaAdenocarcinoma of the RectumAortic Valve StenosisCardiac Conduction Disturbance
Imperial College London is a clinical research sponsor with 11 registered studies on ClinicalTrials.gov, of which 11 are actively recruiting participants. Research covers conditions including Oesophageal Squamous Cell Carcinoma, Oesophageal Adenocarcinoma, Gastric Adenocarcinoma, Pancreatic Ductal Adenocarcinoma (PDAC).
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Imperial College London
How many clinical trials has Imperial College London sponsored?
ClinicalMetric currently tracks 11 clinical trials sponsored by Imperial College London, of which 11 are actively recruiting participants. These trials cover conditions including Oesophageal Squamous Cell Carcinoma, Oesophageal Adenocarcinoma, Gastric Adenocarcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Imperial College London research focus on?
Imperial College London clinical trials span Oesophageal Squamous Cell Carcinoma, Oesophageal Adenocarcinoma, Gastric Adenocarcinoma, Pancreatic Ductal Adenocarcinoma (PDAC), Cholangiocarcinoma, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Imperial College London clinical trial?
To participate in a Imperial College London trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Imperial College London trials with current recruitment status updated daily.
Clinical Trials by Imperial College London
NCT07714538
Recruiting
Breath Research Narrow Validation for Gastrointestinal Cancer Detection
Oesophageal Squamous Cell Carcinoma
NCT03303547
Recruiting
Concordance of Imaging and Pathology Diagnosis of Extranodal Tumour Deposits
Adenocarcinoma of the Rectum
NCT06602609
Recruiting
Remote Cardiovascular Monitoring in Post-TAVI Patients
Aortic Valve Stenosis
NCT05745961
Recruiting
Quantifying 18kDa TSPO Expression in the Lung in Pulmonary Artery Hypertension (PAH)
Pulmonary Arterial Hypertension
NCT03911297
Recruiting
DAISy-PCOS Phenome Study - Dissecting Androgen Excess and Metabolic Dysfunction in Polycystic Ovary Syndrome
Polycystic Ovary Syndrome
NCT05815745
Recruiting
"Physiological vs Right Ventricular Pacing Outcome Trial Evaluated for bradyCardia Treatment" (PROTECT-HF)
Bradycardia
NCT05012033
Recruiting
Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting
Thyroid Eye Disease
NCT07555795
Recruiting
Motivating Core-muscle Exercises With Wearable Sensors, Haptics and Interactive Gaming
Non-specific Low Back Pain
NCT04103372
Recruiting
Pre-therapeutic MRI Assessment of Early-Stage Rectal Cancer and Significant Rectal Polyps to Avoid Major Resectional Surgery
Rectal Cancer
NCT02704520
Recruiting
Magnetic Resonance Tumour Regression Grade (mrTRG) as a Novel Biomarker - Phase III Non CTIMP Trial
Rectal Cancer
NCT05404061
Recruiting
The Poor Responders Study
Bariatric Surgery Candidate
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology